Newsroom

Recent News Releases

March 3, 2021 3/3/2021

Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome

February 26, 2021 2/26/2021

Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited

February 24, 2021 2/24/2021

Takeda Provides Updates on Phase 1/2 Clinical Trials of Novavax’ and Moderna’s COVID-19 Vaccine Candidates in Japan

February 12, 2021 2/12/2021

Takeda's Maribavir Phase 3 Clinical Trial Met Primary Endpoint of Superiority to Conventional Antiviral Therapy in Transplant Recipients With Refractory, With or Without Resistance, Cytomegalovirus Infection/Disease

February 10, 2021 2/10/2021

Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn’s Disease

SEE ALL NEWS AND RELEASES >

・For Shire news releases, click here

Featured Topics

Understanding the Role of Orexin in Sleep and Wakefulness

Learn more

Exploring New Paths in Narcolepsy

Learn more

Spotlight Malawi: Many Paths Towards Universal Health Coverage and a Strong Health Workforce

Learn more

Guided by Our Values: Supporting Global COVID-19 Response

Learn more

A ‘Swiss Cheese’ Approach Can Give Us a Second Chance to Contain COVID-19

Learn more

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.